-transparent.png){kind=logo}
The use of trimethoprim-sulfamethoxazole in the treatment and prophylaxis of Pneumocystis cariniii is well established. Treatment failure with this regimen has been ascribed to inadequate antibiotic serum concentrations. We describe an immunosuppressed patient with recurrent Pneumocystis carinii pneumonia who failed to respond to trimethoprim-sulfamethoxazole therapy despite high antibiotic serum concentrations. Subsequently, a response to pentamidine isethionate was obtained. The reason for failure and therapeutic implications in patients with Pneumocystis carini pneumonia who have received trimethoprim-sulfamethoxazole are discussed.
Related Publications
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
June 1981,
The American journal of medicine,
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
March 1989,
Klinische Wochenschrift,
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
September 1991,
DICP : the annals of pharmacotherapy,
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
August 1991,
AIDS (London, England),
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
April 1999,
The Annals of pharmacotherapy,
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
March 1987,
Annals of internal medicine,
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
June 1980,
Annals of internal medicine,
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
September 1976,
The New England journal of medicine,
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
December 1992,
The Pediatric infectious disease journal,
R T Mitsuyasu, and
H L Corwin, and
A A Harris, and
G M Trenholme, and
S Levi, and
P H Karkusis
October 1992,
Minerva medica,
